SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-251960
Filing Date
2023-10-06
Accepted
2023-10-06 07:56:00
Documents
13
Period of Report
2023-10-03
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d472355d8k.htm   iXBRL 8-K 30522
  Complete submission text file 0001193125-23-251960.txt   189606

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rptx-20231003.xsd EX-101.SCH 3221
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptx-20231003_def.xml EX-101.DEF 13735
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20231003_lab.xml EX-101.LAB 22586
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20231003_pre.xml EX-101.PRE 14551
7 EXTRACTED XBRL INSTANCE DOCUMENT d472355d8k_htm.xml XML 5305
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 231312620
SIC: 2834 Pharmaceutical Preparations